Hemogenyx Pharmaceuticals Plc 5HU.F Stock
Hemogenyx Pharmaceuticals Plc Price Chart
Hemogenyx Pharmaceuticals Plc 5HU.F Financial and Trading Overview
Hemogenyx Pharmaceuticals Plc stock price | 0.01 EUR |
Previous Close | 0.008 EUR |
Open | 0.008 EUR |
Bid | 0.009 EUR x N/A |
Ask | 0.02 EUR x N/A |
Day's Range | 0.008 - 0.008 EUR |
52 Week Range | 0.0075 - 0.05 EUR |
Volume | 200 EUR |
Avg. Volume | 3 EUR |
Market Cap | 16.65M EUR |
Beta (5Y Monthly) | 3.659386 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.01 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
5HU.F Valuation Measures
Enterprise Value | 9.42M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 2.6666667 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -2.412 |
Trading Information
Hemogenyx Pharmaceuticals Plc Stock Price History
Beta (5Y Monthly) | 3.659386 |
52-Week Change | -21.052% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.05 EUR |
52 Week Low | 0.0075 EUR |
50-Day Moving Average | 0.02 EUR |
200-Day Moving Average | 0.01 EUR |
5HU.F Share Statistics
Avg. Volume (3 month) | 3 EUR |
Avg. Daily Volume (10-Days) | 20 EUR |
Shares Outstanding | 1.14B |
Float | 1.01B |
Short Ratio | N/A |
% Held by Insiders | 13.01% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -32.0050% |
Return on Equity (ttm) | -69.87% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -3907581 EUR |
Net Income Avi to Common (ttm) | -3979314 EUR |
Diluted EPS (ttm) | -0.01 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 2.53M EUR |
Total Cash Per Share (mrq) | 0.002 EUR |
Total Debt (mrq) | 3.42M EUR |
Total Debt/Equity (mrq) | 105.53 EUR |
Current Ratio (mrq) | 3.467 |
Book Value Per Share (mrq) | 0.003 |
Cash Flow Statement
Operating Cash Flow (ttm) | -2910604 EUR |
Levered Free Cash Flow (ttm) | -2394851 EUR |
Profile of Hemogenyx Pharmaceuticals Plc
Country | Germany |
State | N/A |
City | London |
Address | 60 Gracechurch Street |
ZIP | EC3V 0HR |
Phone | N/A |
Website | https://www.hemogenyx.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 14 |
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML); HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. The company was founded in 2012 and is headquartered in London, the United Kingdom.
Q&A For Hemogenyx Pharmaceuticals Plc Stock
What is a current 5HU.F stock price?
Hemogenyx Pharmaceuticals Plc 5HU.F stock price today per share is 0.01 EUR.
How to purchase Hemogenyx Pharmaceuticals Plc stock?
You can buy 5HU.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hemogenyx Pharmaceuticals Plc?
The stock symbol or ticker of Hemogenyx Pharmaceuticals Plc is 5HU.F.
Which industry does the Hemogenyx Pharmaceuticals Plc company belong to?
The Hemogenyx Pharmaceuticals Plc industry is Biotechnology.
How many shares does Hemogenyx Pharmaceuticals Plc have in circulation?
The max supply of Hemogenyx Pharmaceuticals Plc shares is 2.18B.
What is Hemogenyx Pharmaceuticals Plc Price to Earnings Ratio (PE Ratio)?
Hemogenyx Pharmaceuticals Plc PE Ratio is now.
What was Hemogenyx Pharmaceuticals Plc earnings per share over the trailing 12 months (TTM)?
Hemogenyx Pharmaceuticals Plc EPS is -0.01 EUR over the trailing 12 months.
Which sector does the Hemogenyx Pharmaceuticals Plc company belong to?
The Hemogenyx Pharmaceuticals Plc sector is Healthcare.